Navigation Links
BIDMC scientists receive creativity awards from Prostate Cancer Foundation
Date:4/14/2009

BOSTON Two projects led by scientists at Beth Israel Deaconess Medical Center (BIDMC) have received funding from the Prostate Cancer Foundation (PCF) as part of their 2009 Creativity Awards program, which supports innovative ideas to improve the detection and treatment of prostate cancer.

The one-year awards were made to 10 projects at nine institutions throughout the U.S., with BIDMC the only institution in New England to be funded and the only institution to receive multiple awards.

PCF Creativity Awards were developed to aid the advancement of the world's most imaginative, new research ideas that are not currently funded by any existing government or private sources.

"We were impressed with the unique ideas represented by the applications we received. A rigorous peer review process vetted the 10 selected projects from a field of more than 300 applications representing 105 institutions in 11 countries," said Howard Soule, PhD, PCF executive vice president and chief scientist. "These awards feed our pipeline of compelling ideas to cultivate new solutions for the prostate cancer problem. Promising results will translate into better therapies for patients with advanced prostate cancer."

Towia Libermann, PhD, and Alan Rigby, PhD, will receive the Michael Vinecki Creativity Award for their work studying Ets factor binding sites on DNA, the first step in selecting candidate prostate cancer inhibitors. "We know that in 40 to 60 percent of prostate cancers, Ets factors are what lies behind both the initial disease and its progression," notes Libermann. He and Rigby will use a state-of-the-art computer-aided drug discovery platform developed in the Rigby laboratory to model the structure of these sites, with the ultimate goal of generating drug candidates to block prostate-cancer progression. Libermann is Director of the BIDMC Genomics and Proteomics Center and of the Dana-Farber/Harvard Cancer Center Proteomics Core in BIDMC's Division of Interdisciplinary Medicine and Biotechnology; Rigby is Interim Director of the Program in Drug Discovery and Target Validation in BIDMC's Center for Vascular Biology Research, Division of Molecular and Vascular Biology.

Pier Paolo Pandolfi, MD, PhD, Director of Research for BIDMC's Cancer Center will receive PCF's Dan Fogleberg Creativity Award for his work on cellular senescence. "Cellular senescence is a process whereby cancer cells 'go to sleep irreversibly,'" explains Pandolfi. Building on earlier work which identified a previously unknown form of senescence in prostate cancer cells, Pandolfi will use specialized animal models of prostate cancer to evaluate chemical compounds to achieve senescence in the cancer stem cell population, which is known to be extremely difficult to eradicate.


'/>"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Source:Eurekalert

Related medicine news :

1. Biotech company cofounded by BIDMC scientists targets natural killer T-cells
2. Healthcare Data Services (HDS) Announces Contract with Beth Israel Deaconess Physician Organization (BIDPO) and Beth Israel Deaconess Medical Center (BIDMC)
3. BIDMC Dyslexia Research Lab celebrates 25th anniversary
4. Scientists discover way to jumpstart bones healing process
5. Scripps research scientists model 3D structures of proteins that control human clock
6. Scientists Identify Key Gene That Protects Against Leukemia
7. Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium
8. Scientists Now Warn That White Wine Can Lead To Teeth Staining
9. Scientists Uncover New Weapon Against Huntingtons
10. Scientists show how a neuron gets its shape
11. Neuroscientists demonstrate link between brainwave acticity and visual perception
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
(Date:6/23/2016)...  Guerbet announced today that it has been named ... . One of 12 suppliers to receive ... support of Premier members through exceptional local customer service ... to lower costs. ... outstanding customer service from Premier," says Massimo Carrara ...
Breaking Medicine Technology: